31 – 40 of 397
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Glucagon and insulin secretion, insulin clearance, and fasting glucose in GIP receptor and GLP-1 receptor knockout mice
(2019) In American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 316(1). p.27-37
- Contribution to journal › Article
-
Mark
Islet adaptation in GIP receptor knockout mice
(2019) In Peptides
- Contribution to journal › Scientific review
- 2018
-
Mark
Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
- Contribution to journal › Article
-
Mark
Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes : A randomized, placebo-controlled study
Farngren, Johan LU ; Persson, Margaretha LU
and Ahrén, Bo
LU
(2018)
In Diabetes, Obesity and Metabolism
20(8).
p.1911-1920
- Contribution to journal › Article
-
Mark
DPP-4 is expressed in human pancreatic beta cells and its direct inhibition improves beta cell function and survival in type 2 diabetes
- Contribution to journal › Article
-
Mark
Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients
Alsalim, Wathik LU ; Persson, Margaretha LU
and Ahrén, Bo
LU
(2018)
In Diabetes, Obesity and Metabolism
20(7).
p.1652-1658
- Contribution to journal › Article
-
Mark
Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors
(2018) In American Journal of Physiology - Regulatory Integrative and Comparative Physiology 314(5). p.639-646
- Contribution to journal › Article
-
Mark
Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects
Alsalim, Wathik LU ; Göransson, Olga LU
; Carr, Richard D.
; Bizzotto, Roberto
; Tura, Andrea
; Pacini, Giovanni
; Mari, Andrea
and Ahrén, Bo
LU
(2018)
In Diabetes, Obesity and Metabolism
20(4).
p.1080-1085
- Contribution to journal › Article
-
Mark
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
- Contribution to journal › Article
- 2017
-
Mark
The vildagliptin experience - 25 years since the initiation of the novartis glucagon-like peptide-1 based therapy programme and 10 years since the first vildagliptin registration
- Contribution to journal › Article